GSK Gets Wellbutrin Pay-For-Delay Antitrust Suit Nixed
A Pennsylvania federal judge nixed claims from consumers and wholesalers Wednesday that GlaxoSmithKline paid off generic rivals to keep cheaper versions of antidepressant Wellbutrin XL off the market, ruling that buyers...To view the full article, register now.
Already a subscriber? Click here to view full article